Combining Treatment Benefits Lung Cancer Patients With Resistance to Anticancer Therapies
Lung cancer News, News
Combining afatinib and cetuximab produced positive clinical responses in lung cancer patients with epidermal growth factor receptor (EGFR) mutations that had developed resistance to EGFR inhibitors erlotinib and gefitinib. These ... Read more